Oak Thistle LLC Grows Stake in Teleflex Incorporated (NYSE:TFX)

Oak Thistle LLC lifted its stake in Teleflex Incorporated (NYSE:TFX) by 243.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 10,695 shares of the medical technology company’s stock after buying an additional 7,585 shares during the period. Teleflex makes up 0.6% of Oak Thistle LLC’s portfolio, making the stock its 29th biggest position. Oak Thistle LLC’s holdings in Teleflex were worth $1,903,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors have also modified their holdings of the company. Mendota Financial Group LLC purchased a new position in Teleflex in the 4th quarter worth approximately $124,000. Bridge Creek Capital Management LLC lifted its position in shares of Teleflex by 1.7% during the fourth quarter. Bridge Creek Capital Management LLC now owns 16,730 shares of the medical technology company’s stock worth $2,978,000 after purchasing an additional 285 shares in the last quarter. Czech National Bank boosted its stake in shares of Teleflex by 4.9% in the fourth quarter. Czech National Bank now owns 10,070 shares of the medical technology company’s stock valued at $1,792,000 after purchasing an additional 472 shares during the period. Wealth Enhancement Advisory Services LLC grew its holdings in Teleflex by 4.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,305 shares of the medical technology company’s stock valued at $588,000 after purchasing an additional 128 shares in the last quarter. Finally, First Hawaiian Bank increased its stake in Teleflex by 12.8% during the 4th quarter. First Hawaiian Bank now owns 4,282 shares of the medical technology company’s stock worth $762,000 after buying an additional 487 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Price Performance

Shares of NYSE TFX opened at $179.00 on Wednesday. The company has a current ratio of 2.42, a quick ratio of 1.39 and a debt-to-equity ratio of 0.37. The company has a market capitalization of $8.31 billion, a price-to-earnings ratio of 35.59, a price-to-earnings-growth ratio of 1.84 and a beta of 1.16. Teleflex Incorporated has a twelve month low of $171.69 and a twelve month high of $256.85. The business has a 50 day simple moving average of $185.27 and a 200-day simple moving average of $216.16.

Teleflex (NYSE:TFX) last released its quarterly earnings data on Thursday, October 31st. The medical technology company reported $3.49 EPS for the quarter, topping analysts’ consensus estimates of $3.38 by $0.11. The firm had revenue of $764.40 million during the quarter, compared to the consensus estimate of $768.68 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm’s revenue was up 2.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $3.64 earnings per share. As a group, equities research analysts expect that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 16th. Investors of record on Friday, November 15th were paid a dividend of $0.34 per share. The ex-dividend date was Friday, November 15th. This represents a $1.36 annualized dividend and a yield of 0.76%. Teleflex’s dividend payout ratio (DPR) is 27.04%.

Analyst Ratings Changes

A number of equities analysts have weighed in on TFX shares. Royal Bank of Canada decreased their price objective on shares of Teleflex from $275.00 to $245.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. StockNews.com raised Teleflex from a “hold” rating to a “buy” rating in a report on Thursday, November 28th. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a report on Monday, December 16th. Truist Financial reduced their target price on Teleflex from $227.00 to $200.00 and set a “hold” rating for the company in a research note on Wednesday, December 18th. Finally, Mizuho dropped their price target on shares of Teleflex from $275.00 to $250.00 and set a “neutral” rating for the company in a research note on Friday, November 1st. Three equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $252.50.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.